(4-Methyl-piperazin-1-yl)-[8-(3-nitro-phenyl)-[1,7]naphthyridin-6-yl]-methanone

ID: ALA161602

PubChem CID: 10547592

Max Phase: Preclinical

Molecular Formula: C20H19N5O3

Molecular Weight: 377.40

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CCN(C(=O)c2cc3cccnc3c(-c3cccc([N+](=O)[O-])c3)n2)CC1

Standard InChI:  InChI=1S/C20H19N5O3/c1-23-8-10-24(11-9-23)20(26)17-13-15-5-3-7-21-18(15)19(22-17)14-4-2-6-16(12-14)25(27)28/h2-7,12-13H,8-11H2,1H3

Standard InChI Key:  ODTOBENNZQIDCO-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    2.3042    0.2083    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8292   -1.8875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3000    0.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7875   -0.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8167    1.1208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3375    0.8208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2625    0.2000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7875   -0.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3167   -1.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7750    1.1083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2542    0.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3125   -0.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3792    0.2333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8292   -2.4792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7417   -0.0917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5417   -1.7417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8042    1.7208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3417    0.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8500    1.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3750    0.8333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8625   -0.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2667   -1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8000   -1.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9000   -0.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2750   -1.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7417    1.1083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2250    0.2000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2250    0.8083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  9  1  0
  3  1  2  0
  4  1  1  0
  5  3  1  0
  6  5  1  0
  7  4  2  0
  8  4  1  0
  9 12  2  0
 10  3  1  0
 11  7  1  0
 12  8  1  0
 13 20  1  0
 14  2  1  0
 15  7  1  0
 16  2  2  0
 17  5  2  0
 18  6  1  0
 19  6  1  0
 20 19  1  0
 21 18  1  0
 22  8  2  0
 23 25  2  0
 24 13  1  0
 25 22  1  0
 26 11  1  0
 27 15  2  0
 28 27  1  0
 11 10  2  0
  9 23  1  0
 26 28  2  0
 13 21  1  0
M  CHG  2   2   1  14  -1
M  END

Associated Targets(Human)

PDE4A Tclin Phosphodiesterase 4A (1943 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4C Tclin Phosphodiesterase 4C (258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4D Tclin Phosphodiesterase 4D (3546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3 (1749 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pde4b Phosphodiesterase 4B (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde4d Phosphodiesterase 4 (578 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 377.40Molecular Weight (Monoisotopic): 377.1488AlogP: 2.59#Rotatable Bonds: 3
Polar Surface Area: 92.47Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.67CX LogP: 2.42CX LogD: 2.34
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.51Np Likeness Score: -1.61

References

1. Hersperger R, Bray-French K, Mazzoni L, Müller T..  (2000)  Palladium-catalyzed cross-coupling reactions for the synthesis of 6, 8-disubstituted 1,7-naphthyridines: a novel class of potent and selective phosphodiesterase type 4D inhibitors.,  43  (4): [PMID:10691693] [10.1021/jm991094u]

Source